請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47428完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 程蘊菁(Yen-Ching Karen Chen) | |
| dc.contributor.author | Yen-Ling Lin | en |
| dc.contributor.author | 林彥伶 | zh_TW |
| dc.date.accessioned | 2021-06-15T05:59:23Z | - |
| dc.date.available | 2012-09-09 | |
| dc.date.copyright | 2010-09-09 | |
| dc.date.issued | 2010 | |
| dc.date.submitted | 2010-08-17 | |
| dc.identifier.citation | Alexander, R. W. (1995). Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25(2): 155-161.
Bell, R. D., A. P. Sagare, A. E. Friedman, G. S. Bedi, D. M. Holtzman, R. Deane and B. V. Zlokovic (2007). Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27(5): 909-918. Bertram, L., M. B. McQueen, K. Mullin, D. Blacker and R. E. Tanzi (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39(1): 17-23. Butler, A. W., M. Y. Ng, M. L. Hamshere, P. Forabosco, R. Wroe, A. Al-Chalabi, C. M. Lewis and J. F. Powell (2009). Meta-analysis of linkage studies for Alzheimer's disease--a web resource. Neurobiol Aging 30(7): 1037-1047. Calero, M., A. Rostagno, E. Matsubara, B. Zlokovic, B. Frangione and J. Ghiso (2000). Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc Res Tech 50(4): 305-315. Calero, M., T. Tokuda, A. Rostagno, A. Kumar, B. Zlokovic, B. Frangione and J. Ghiso (1999). Functional and structural properties of lipid-associated apolipoprotein J (clusterin). Biochem J 344 Pt 2: 375-383. Chen, H. H. and C. J. Hu (2006). Genetic characteristics of dementia in Taiwan. Acta Neurol Taiwan 15(3): 161-169. Chen, Y. C., E. Giovannucci, R. Lazarus, P. Kraft, S. Ketkar and D. J. Hunter (2005). Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 65(24): 11771-11778. Corder, E. H., A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses, J. L. Haines and M. A. Pericak-Vance (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261(5123): 921-923. Davignon, J., R. E. Gregg and C. F. Sing (1988). Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8(1): 1-21. DeMattos, R. B., A. O'Dell M, M. Parsadanian, J. W. Taylor, J. A. Harmony, K. R. Bales, S. M. Paul, B. J. Aronow and D. M. Holtzman (2002). Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 99(16): 10843-10848. Evans, D. A., L. A. Beckett, T. S. Field, L. Feng, M. S. Albert, D. A. Bennett, B. Tycko and R. Mayeux (1997). Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA 277(10): 822-824. Ferri, C. P., M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, M. Ganguli, K. Hall, K. Hasegawa, H. Hendrie, Y. Huang, A. Jorm, C. Mathers, P. R. Menezes, E. Rimmer and M. Scazufca (2005). Global prevalence of dementia: a Delphi consensus study. Lancet 366(9503): 2112-2117. Folstein, M., S. Folstein, P. McHugh and G. Fanjiang (1983). Mini-Mental State Examination (MMSE). Arch Gen Psychiatry 40: 812. Fuh, J. L. and S. J. Wang (2008). Dementia in Taiwan: past, present, and future. Acta Neurol Taiwan 17(3): 153-161. Gabriel, S. B., S. F. Schaffner, H. Nguyen, J. M. Moore, J. Roy, B. Blumenstiel, J. Higgins, M. DeFelice, A. Lochner, M. Faggart, S. N. Liu-Cordero, C. Rotimi, A. Adeyemo, R. Cooper, R. Ward, E. S. Lander, M. J. Daly and D. Altshuler (2002). The structure of haplotype blocks in the human genome. Science 296(5576): 2225-2229. Gabriel, S. B., S. F. Schaffner, H. Nguyen, J. M. Moore, J. Roy, B. Blumenstiel, J. Higgins, M. DeFelice, A. Lochner, M. Faggart, S. N. Liu-Cordero, C. Rotimi, A. Adeyemo, R. Cooper, R. Ward, E. S. Lander, M. J. Daly and D. Altshuler (2002). The structure of haplotype blocks in the human genome. Science 296(5576): 2225-2229. Gatz, M., C. A. Reynolds, L. Fratiglioni, B. Johansson, J. A. Mortimer, S. Berg, A. Fiske and N. L. Pedersen (2006). Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63(2): 168-174. Giannakopoulos, P., E. Kovari, L. E. French, I. Viard, P. R. Hof and C. Bouras (1998). Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study. Acta Neuropathol 95(4): 387-394. Guerreiro, R. J., J. Beck, J. R. Gibbs, I. Santana, M. N. Rossor, J. M. Schott, M. A. Nalls, H. Ribeiro, B. Santiago, N. C. Fox, C. Oliveira, J. Collinge, S. Mead, A. Singleton and J. Hardy (2010). Genetic variability in CLU and its association with Alzheimer's disease. PLoS One 5(3): e9510. Harold, D., R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, M. L. Hamshere, J. S. Pahwa, V. Moskvina, K. Dowzell, A. Williams, N. Jones, C. Thomas, A. Stretton, A. R. Morgan, S. Lovestone, J. Powell, P. Proitsi, M. K. Lupton, C. Brayne, D. C. Rubinsztein, M. Gill, B. Lawlor, A. Lynch, K. Morgan, K. S. Brown, P. A. Passmore, D. Craig, B. McGuinness, S. Todd, C. Holmes, D. Mann, A. D. Smith, S. Love, P. G. Kehoe, J. Hardy, S. Mead, N. Fox, M. Rossor, J. Collinge, W. Maier, F. Jessen, B. Schurmann, H. van den Bussche, I. Heuser, J. Kornhuber, J. Wiltfang, M. Dichgans, L. Frolich, H. Hampel, M. Hull, D. Rujescu, A. M. Goate, J. S. Kauwe, C. Cruchaga, P. Nowotny, J. C. Morris, K. Mayo, K. Sleegers, K. Bettens, S. Engelborghs, P. P. De Deyn, C. Van Broeckhoven, G. Livingston, N. J. Bass, H. Gurling, A. McQuillin, R. Gwilliam, P. Deloukas, A. Al-Chalabi, C. E. Shaw, M. Tsolaki, A. B. Singleton, R. Guerreiro, T. W. Muhleisen, M. M. Nothen, S. Moebus, K. H. Jockel, N. Klopp, H. E. Wichmann, M. M. Carrasquillo, V. S. Pankratz, S. G. Younkin, P. A. Holmans, M. O'Donovan, M. J. Owen and J. Williams (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41(10): 1088-1093. Harr, S. D., L. Uint, R. Hollister, B. T. Hyman and A. J. Mendez (1996). Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem 66(6): 2429-2435. Hebert, L. E., L. A. Beckett, P. A. Scherr and D. A. Evans (2001). Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 15(4): 169-173. Holtzman, D. M. (2004). In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J Mol Neurosci 23(3): 247-254. Ishikawa, Y., Y. Akasaka, T. Ishii, K. Komiyama, S. Masuda, N. Asuwa, N. H. Choi-Miura and M. Tomita (1998). Distribution and synthesis of apolipoprotein J in the atherosclerotic aorta. Arterioscler Thromb Vasc Biol 18(4): 665-672. Jones, L., D. Harold and J. Williams (2010). Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease. Biochim Biophys Acta. Jones, S. E. and C. Jomary (2002). Clusterin. International Journal of Biochemistry and Cell Biology 34(5): 427-431. Kalaria, R. N. (1999). The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann N Y Acad Sci 893: 113-125. Kirszbaum, L., S. E. Bozas and I. D. Walker (1992). SP-40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges. FEBS Lett 297(1-2): 70-76. Lambert, J. C., S. Heath, G. Even, D. Campion, K. Sleegers, M. Hiltunen, O. Combarros, D. Zelenika, M. J. Bullido, B. Tavernier, L. Letenneur, K. Bettens, C. Berr, F. Pasquier, N. Fievet, P. Barberger-Gateau, S. Engelborghs, P. De Deyn, I. Mateo, A. Franck, S. Helisalmi, E. Porcellini, O. Hanon, M. M. de Pancorbo, C. Lendon, C. Dufouil, C. Jaillard, T. Leveillard, V. Alvarez, P. Bosco, M. Mancuso, F. Panza, B. Nacmias, P. Bossu, P. Piccardi, G. Annoni, D. Seripa, D. Galimberti, D. Hannequin, F. Licastro, H. Soininen, K. Ritchie, H. Blanche, J. F. Dartigues, C. Tzourio, I. Gut, C. Van Broeckhoven, A. Alperovitch, M. Lathrop and P. Amouyel (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41(10): 1094-1099. Liu, P., H. G. Vikis, Y. Lu, Y. Wang, A. G. Schwartz, S. M. Pinney, P. Yang, M. de Andrade, A. Gazdar, C. Gaba, D. Mandal, J. Lee, E. Kupert, D. Seminara, J. Minna, J. E. Bailey-Wilson, C. I. Amos, M. W. Anderson and M. You (2010). Cumulative effect of multiple loci on genetic susceptibility to familial lung cancer. Cancer Epidemiol Biomarkers Prev 19(2): 517-524. McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price and E. Stadlan (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7): 939. Miwa, Y., S. Takiuchi, K. Kamide, M. Yoshii, T. Horio, C. Tanaka, M. Banno, T. Miyata, T. Sasaguri and Y. Kawano (2005). Insertion/deletion polymorphism in clusterin gene influences serum lipid levels and carotid intima-media thickness in hypertensive Japanese females. Biochem Biophys Res Commun 331(4): 1587-1593. Morris, J. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43(11): 2412-2414. Myers, R. H., E. J. Schaefer, P. W. Wilson, R. D'Agostino, J. M. Ordovas, A. Espino, R. Au, R. F. White, J. E. Knoefel, J. L. Cobb, K. A. McNulty, A. Beiser and P. A. Wolf (1996). Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology 46(3): 673-677. Nuutinen, T., T. Suuronen, A. Kauppinen and A. Salminen (2009). Clusterin: a forgotten player in Alzheimer's disease. Brain Res Rev 61(2): 89-104. Organization, W. H. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva, Switzerland: World Health Organisation. Pfeiffer, E. (1975). A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. Journal of the American Geriatrics Society 23(10): 433. Saunders, A. M., K. Schmader, J. C. Breitner, M. D. Benson, W. T. Brown, L. Goldfarb, D. Goldgaber, M. G. Manwaring, M. H. Szymanski, N. McCown and et al. (1993). Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342(8873): 710-711. Seshadri, S., A. L. Fitzpatrick, M. A. Ikram, A. L. DeStefano, V. Gudnason, M. Boada, J. C. Bis, A. V. Smith, M. M. Carassquillo, J. C. Lambert, D. Harold, E. M. Schrijvers, R. Ramirez-Lorca, S. Debette, W. T. Longstreth, Jr., A. C. Janssens, V. S. Pankratz, J. F. Dartigues, P. Hollingworth, T. Aspelund, I. Hernandez, A. Beiser, L. H. Kuller, P. J. Koudstaal, D. W. Dickson, C. Tzourio, R. Abraham, C. Antunez, Y. Du, J. I. Rotter, Y. S. Aulchenko, T. B. Harris, R. C. Petersen, C. Berr, M. J. Owen, J. Lopez-Arrieta, B. N. Varadarajan, J. T. Becker, F. Rivadeneira, M. A. Nalls, N. R. Graff-Radford, D. Campion, S. Auerbach, K. Rice, A. Hofman, P. V. Jonsson, H. Schmidt, M. Lathrop, T. H. Mosley, R. Au, B. M. Psaty, A. G. Uitterlinden, L. A. Farrer, T. Lumley, A. Ruiz, J. Williams, P. Amouyel, S. G. Younkin, P. A. Wolf, L. J. Launer, O. L. Lopez, C. M. van Duijn and M. M. Breteler (2010). Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303(18): 1832-1840. Sleegers, K., J. C. Lambert, L. Bertram, M. Cruts, P. Amouyel and C. Van Broeckhoven (2010). The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet 26(2): 84-93. Statistics, A. P. A. C. o. N. a. (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), Fourth Edition. Washington, DC: American Psychiatric Association. Stram, D. O., C. Leigh Pearce, P. Bretsky, M. Freedman, J. N. Hirschhorn, D. Altshuler, L. N. Kolonel, B. E. Henderson and D. C. Thomas (2003). Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 55(4): 179-190. Taylor, K. D., S. R. Targan, L. Mei, A. F. Ippoliti, D. McGovern, E. Mengesha, L. King and J. I. Rotter (2008). IL23R haplotypes provide a large population attributable risk for Crohn's disease. Inflamm Bowel Dis 14(9): 1185-1191. Tycko, B., L. Feng, L. Nguyen, A. Francis, A. Hays, W. Y. Chung, M. X. Tang, Y. Stern, A. Sahota, H. Hendrie and R. Mayeux (1996). Polymorphisms in the human apolipoprotein-J/clusterin gene: ethnic variation and distribution in Alzheimer's disease. Hum Genet 98(4): 430-436. Wilson, M. R., J. J. Yerbury and S. Poon (2008). Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity. Mol Biosyst 4(1): 42-52. Wood, W. G., F. Schroeder, N. A. Avdulov, S. V. Chochina and U. Igbavboa (1999). Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease. Lipids 34(3): 225-234. Xu, J., K. D. Kochanek and B. Tejada-Vera (2009). Deaths: preliminary data for 2007. Division of Vital Statistics, National Vital Statistics Reports 58(1): 1-51. Yerbury, J. J., S. Poon, S. Meehan, B. Thompson, J. R. Kumita, C. M. Dobson and M. R. Wilson (2007). The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J 21(10): 2312-2322. Zaykin, D. V., P. H. Westfall, S. S. Young, M. A. Karnoub, M. J. Wagner and M. G. Ehm (2002). Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53(2): 79-91. Zheng, S. L., J. Sun, F. Wiklund, S. Smith, P. Stattin, G. Li, H. O. Adami, F. C. Hsu, Y. Zhu, K. Balter, A. K. Kader, A. R. Turner, W. Liu, E. R. Bleecker, D. A. Meyers, D. Duggan, J. D. Carpten, B. L. Chang, W. B. Isaacs, J. Xu and H. Gronberg (2008). Cumulative association of five genetic variants with prostate cancer. N Engl J Med 358(9): 910-919. Zlokovic, B. V. (1996). Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier. Life Sci 59(18): 1483-1497. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/47428 | - |
| dc.description.abstract | 背景. Clusterin (CLU)在阿茲海默症的致病機轉中可能和脂質代謝和類澱粉斑(Aβ)的清除有關。近期的全基因關聯研究發現CLU基因與阿茲海默症風險有相關。
方法. 自2007到2010年間，我們以病例對照的研究，在三間教學醫院的神經內科門診招募278位阿茲海默症患者，同一時間內，另招募422位來自醫院的志工與參加老人健康檢查之民眾做為對照組。本研究共挑選了4個常見的(對偶基因頻率> 5%) haplotype-tagging單核苷酸多型性(htSNP)來分析CLU基因多型性與阿茲海默症的關聯。為了探討CLU基因多型性與ApoE ε4對偶基因、性別以及高血壓的交互作用對阿茲海默症風險之影響，另進行分層分析。 結果. 研究結果顯示帶有rs11136000變異的對偶基因會降低阿茲海默症風險[2 vs. 0 copies: odds ratio (OR) = 0.17, 95% confidence interval (CI) = 0.05-0.60]。由所選的4個htSNP組成的常見的單倍體(haplotype)，共有5個(累積頻率為95.9%)，其中帶有兩個變異的單倍體TATT會顯著降低阿茲海默症風險(2 vs. 0 copies: OR = 0.19, 95% CI = 0.05-0.66)。我們也發現CLU單倍體與高血壓有交互作用存在(P值為0.04)。 結論. 此研究發現CLU基因多型性與阿茲海默症風險有關，這些遺傳標記可做為阿茲海默症的重要預測因子。 | zh_TW |
| dc.description.abstract | Background. Clusterin (CLU) is involved in lipid metabolism and beta amyloid (Aβ) clearance, which have been related to the pathogenesis of Alzheimer’s disease (AD). Recent genome-wide association studies have found that CLU genetic polymorphisms were associated with AD risk.
Methods. AD cases (n = 278) were recruited from Department of Neurology at three teaching hospitals in Taiwan between 2007 and 2010. Controls (n = 422) were recruited from the elderly health check-up and volunteers in the hospital during the same time period. Four common (allele frequency > 5%) haplotype-tagging single nucleotide polymorphisms (htSNPs) were selected to examine the association between sequence variants of CLU and AD. We also assessed how ApoE ε4 status, gender, and hypertension modify the association between CLU polymorphisms and AD risk. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T05:59:23Z (GMT). No. of bitstreams: 1 ntu-99-R97842011-1.pdf: 873458 bytes, checksum: a5f1ff98bf1e008f43c96b82ec544203 (MD5) Previous issue date: 2010 | en |
| dc.description.tableofcontents | 口試委員會審定書 i
致謝 ii 摘要 iii ABSTRACT iv CONTENT vi List of figures viii List of tables ix Chapter 1. Introduction 1 1.1 Dementia 1 1.2 Clusterin gene 1 1.3 Previous studies 2 Chapter 2. Materials and methods 4 2.1 Study population 4 2.2 Ascertainment of dementia 5 2.3 Laboratory assays 5 2.4 Statistical analysis 6 Chapter 3. Results 8 3.1 Characteristics of the study population 8 3.2 CLU SNPs and AD risk 8 3.3 CLU haplotypes and AD risk 9 3.4 ApoE genotype frequencies and stratification by ApoE e4 status 10 3.5 Effect modification by hypertension 11 Chapter 4.Discussion 12 4.1 Main findings 12 4.2 CLU mechanism 12 4.3 Comparison with previously studies 13 4.4 Strengths and limitations 15 4.5 Conclusion 15 References 16 | |
| dc.language.iso | en | |
| dc.subject | 群集素 | zh_TW |
| dc.subject | 阿茲海默症 | zh_TW |
| dc.subject | 載脂蛋白E | zh_TW |
| dc.subject | 單倍型 | zh_TW |
| dc.subject | 單核苷 | zh_TW |
| dc.subject | 酸多型性 | zh_TW |
| dc.subject | 單倍型標記核苷 | zh_TW |
| dc.subject | 酸多型性 | zh_TW |
| dc.subject | haplotype-tagging single nucleotide polymorphism | en |
| dc.subject | Alzheimer's disease | en |
| dc.subject | haplotype | en |
| dc.subject | single nucleotide polymorphism | en |
| dc.subject | Clusterin | en |
| dc.subject | ApoE | en |
| dc.title | Clusterin基因多型性與阿茲海默症風險之關聯研究 | zh_TW |
| dc.title | Genetic Polymorphisms of Clusterin Gene and the Risk of Alzheimer's Disease | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 98-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.coadvisor | 陳為堅(Wei J. Chen) | |
| dc.contributor.oralexamcommittee | 宋鴻樟(Fung-Chang Sung),蕭朱杏(Chuhsing Kate Hsiao),簡國龍(Kuo-Liong Chien) | |
| dc.subject.keyword | 阿茲海默症,群集素,載脂蛋白E,單倍型,單核苷,酸多型性,單倍型標記核苷,酸多型性, | zh_TW |
| dc.subject.keyword | Alzheimer's disease,Clusterin,ApoE,haplotype,single nucleotide polymorphism,haplotype-tagging single nucleotide polymorphism, | en |
| dc.relation.page | 34 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2010-08-17 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學研究所 | zh_TW |
| 顯示於系所單位： | 流行病學與預防醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-99-1.pdf 未授權公開取用 | 852.99 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。